154 related articles for article (PubMed ID: 24298484)
1. A comparative study of clinical profiles of vivax and falciparum malaria in children at a tertiary care centre in uttarakhand.
Singh R; Kumar S; Rana SK; Thakur B; Singh SP
J Clin Diagn Res; 2013 Oct; 7(10):2234-7. PubMed ID: 24298484
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Clinical Profile between P. vivax and P. falciparum Malaria in Children: A Tertiary Care Centre Perspective from India.
Goyal JP; Makwana AM
Malar Res Treat; 2014; 2014():132672. PubMed ID: 24812588
[TBL] [Abstract][Full Text] [Related]
3. Changing pattern of severe manifestations of
Acharya J; Harwani D
J Vector Borne Dis; 2022; 59(3):259-264. PubMed ID: 36511043
[TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of clinic-laboratory profile of different species of severe malaria in a tertiary care institute in southern India.
Kuncheria T; Chowta NK; Madi D; Chowta MN; Basavaprabhu A
J Vector Borne Dis; 2019; 56(4):360-366. PubMed ID: 33269737
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile and severity of
Badugu V; Gaur BK; Maini B
J Vector Borne Dis; 2023; 60(3):252-258. PubMed ID: 37843235
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of vivax malaria patients presenting to tertiary referral centre of Uttarakhand.
Srivastava S; Ahmad S; Shirazi N; Kumar Verma S; Puri P
Acta Trop; 2011 Feb; 117(2):82-5. PubMed ID: 20943199
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of children hospitalized with malaria--a study from Bikaner, northwest India.
Kochar DK; Tanwar GS; Khatri PC; Kochar SK; Sengar GS; Gupta A; Kochar A; Middha S; Acharya J; Saxena V; Pakalapati D; Garg S; Das A
Am J Trop Med Hyg; 2010 Nov; 83(5):981-9. PubMed ID: 21036824
[TBL] [Abstract][Full Text] [Related]
8. The study of complications of vivax malaria in comparison with falciparum malaria in Mumbai.
Limaye CS; Londhey VA; Nabar ST
J Assoc Physicians India; 2012 Oct; 60():15-8. PubMed ID: 23777019
[TBL] [Abstract][Full Text] [Related]
9. Emerging new trends of malaria in children: a study from a tertiary care centre in northern India.
Mittal M; Jain R; Talukdar B; Kumar M; Kapoor K
J Vector Borne Dis; 2014 Jun; 51(2):115-8. PubMed ID: 24947218
[TBL] [Abstract][Full Text] [Related]
10. Trends in clinical features and severity of Plasmodium vivax malaria among children at tertiary care center in North India.
Arya A; Meena SS; Matlani M; Chaudhry S; Singh V
J Trop Pediatr; 2023 Oct; 69(6):. PubMed ID: 37864522
[TBL] [Abstract][Full Text] [Related]
11. A prospective study from south India to compare the severity of malaria caused by Plasmodium vivax, P. falciparum and dual infection.
Mitra S; Abhilash K; Arora S; Miraclin A
J Vector Borne Dis; 2015 Dec; 52(4):281-6. PubMed ID: 26714506
[TBL] [Abstract][Full Text] [Related]
12. Mortality in Malaria: Intensive Care (MIMIC).
Trivedi T; Bajaj P; Moulick N; Padwal N
J Assoc Physicians India; 2018 Apr; 66(4):16-20. PubMed ID: 30347945
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium vivax malaria admissions and risk of mortality in a tertiary-care children's hospital in North India.
Sharma R; Gohain S; Chandra J; Kumar V; Chopra A; Chatterjee S; Aneja S; Dutta AK
Paediatr Int Child Health; 2012 Aug; 32(3):152-7. PubMed ID: 22824663
[TBL] [Abstract][Full Text] [Related]
14. Demographic and clinical profiles of Plasmodium falciparum and Plasmodium vivax patients at a tertiary care centre in southwestern India.
Chery L; Maki JN; Mascarenhas A; Walke JT; Gawas P; Almeida A; Fernandes M; Vaz M; Ramanan R; Shirodkar D; Bernabeu M; Manoharan SK; Pereira L; Dash R; Sharma A; Shaik RB; Chakrabarti R; Babar P; White J; Mudeppa DG; Kumar S; Zuo W; Skillman KM; Kanjee U; Lim C; Shaw-Saliba K; Kumar A; Valecha N; Jindal VN; Khandeparkar A; Naik P; Amonkar S; Duraisingh MT; Tuljapurkar S; Smith JD; Dubhashi N; Pinto RG; Silveria M; Gomes E; Rathod PK
Malar J; 2016 Nov; 15(1):569. PubMed ID: 27884146
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors related to poor outcome of patients with severe Plasmodium vivax infection: a systematic review, meta-analysis, and analysis of case reports.
Kotepui M; Kotepui KU; Milanez GJ; Masangkay FR
BMC Infect Dis; 2020 May; 20(1):363. PubMed ID: 32448216
[TBL] [Abstract][Full Text] [Related]
17. Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India.
Matlani M; Kojom LP; Mishra N; Dogra V; Singh V
Ann Clin Microbiol Antimicrob; 2020 Oct; 19(1):49. PubMed ID: 33126884
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular involvement in severe vivax and falciparum malaria.
Nayak KC; Meena SL; Gupta BK; Kumar S; Pareek V
J Vector Borne Dis; 2013 Dec; 50(4):285-91. PubMed ID: 24499851
[TBL] [Abstract][Full Text] [Related]
19. Complications associated with Plasmodium vivax malaria: a retrospective study from a tertiary care hospital based in Western Uttar Pradesh, India.
Rizvi I; Tripathi DK; Chughtai AM; Beg M; Zaman S; Zaidi N
Ann Afr Med; 2013; 12(3):155-9. PubMed ID: 24005587
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile of severe Plasmodium vivax malaria in a tertiary care centre in Mumbai from June 2010-January 2011.
Nadkar MY; Huchche AM; Singh R; Pazare AR
J Assoc Physicians India; 2012 Oct; 60():11-3. PubMed ID: 23777018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
